Helius Medical Technologies is trading 5.42% up at $1.75; no company-specific announcement on August 18, 2026 was found to explicitly explain the move.
- August 14 results showed $2.5 million in Q2 revenue, a Tokyo validator-cluster milestone, and a $0.38 per-share net loss, creating mixed signals.
- Broader markets are declining, while crypto is modestly higher, offering limited directional confirmation.